PH12016502047A1 - Niacinamide for including generation of antimicrobial peptides - Google Patents

Niacinamide for including generation of antimicrobial peptides

Info

Publication number
PH12016502047A1
PH12016502047A1 PH12016502047A PH12016502047A PH12016502047A1 PH 12016502047 A1 PH12016502047 A1 PH 12016502047A1 PH 12016502047 A PH12016502047 A PH 12016502047A PH 12016502047 A PH12016502047 A PH 12016502047A PH 12016502047 A1 PH12016502047 A1 PH 12016502047A1
Authority
PH
Philippines
Prior art keywords
niacinamide
antimicrobial peptides
including generation
skin
generation
Prior art date
Application number
PH12016502047A
Other languages
English (en)
Inventor
Majumdar Amitabha
Mathapathi Mruthyunjaya Swamy
Palanisamy Bharath
Sampath Kumar Ramya
Tiwari Jyoti Kumar
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of PH12016502047A1 publication Critical patent/PH12016502047A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH12016502047A 2014-05-12 2016-10-14 Niacinamide for including generation of antimicrobial peptides PH12016502047A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2014/059590 WO2015172801A1 (en) 2014-05-12 2014-05-12 Niacinamide for inducing generation of antimicrobial peptides

Publications (1)

Publication Number Publication Date
PH12016502047A1 true PH12016502047A1 (en) 2017-01-09

Family

ID=50771476

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016502047A PH12016502047A1 (en) 2014-05-12 2016-10-14 Niacinamide for including generation of antimicrobial peptides

Country Status (8)

Country Link
JP (1) JP6446065B2 (es)
CN (2) CN106413680A (es)
BR (1) BR112016024400A2 (es)
EA (1) EA031758B1 (es)
MX (1) MX2016014760A (es)
PH (1) PH12016502047A1 (es)
WO (1) WO2015172801A1 (es)
ZA (1) ZA201607105B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3851093B1 (en) 2015-08-10 2024-05-22 Mary Kay, Inc. Topical compositions
KR102643373B1 (ko) 2015-10-05 2024-03-07 유니레버 글로벌 아이피 리미티드 피부 라이트닝 조성물
BR112018072388B1 (pt) * 2016-05-10 2021-11-16 Unilever Ip Holdings B.V. Composiqao topica, metodo nao-terapeutico de desinfecqao de uma superficie e usos naoterapeuticos de uma composiqao
CA3023369A1 (en) 2016-05-26 2017-11-30 Unilever Plc Antimicrobial compositions for topical use
EP3426276B1 (en) 2017-05-24 2024-01-24 Follea International Synephrine compositions
CN111295190A (zh) * 2017-10-30 2020-06-16 荷兰联合利华有限公司 烟酰胺用于微生物组平衡的用途
CN111683649A (zh) * 2017-12-18 2020-09-18 荷兰联合利华有限公司 基于烟酰胺衍生物的局部组合物
US11793741B2 (en) 2017-12-18 2023-10-24 Conopco, Inc. Topical composition
CN111787903B (zh) 2018-03-13 2023-08-15 联合利华知识产权控股有限公司 消毒剂组合物
WO2024041911A1 (en) * 2022-08-25 2024-02-29 Unilever Ip Holdings B.V. A nasal drop composition and device thereof
WO2024042554A1 (en) * 2022-08-25 2024-02-29 Istituto Fondazione Di Oncologia Molecolare Ets A pharmaceutical composition for treatment of viral infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US7026308B1 (en) * 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
EP1802296A1 (en) * 2004-10-15 2007-07-04 Bayer Consumer Care AG Acidic and buffered skin-scare compositions comprising nicotin amid an absorbing agent
CN101019865A (zh) * 2007-01-23 2007-08-22 中国医学科学院皮肤病医院 抗炎、保湿、祛斑的复方烟酰胺药用组合物
WO2011133692A1 (en) * 2010-04-20 2011-10-27 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
US20130217655A1 (en) * 2010-10-10 2013-08-22 Dermipsor Ltd. Compositions for treating psoriasis of the scalp
FR2973699B1 (fr) * 2011-04-05 2013-04-26 Oreal Nouvel actif apte a induire au stimuler la production de peptides anti microbiens dans le cuir chevelu, utile pour prevenir et/ou traiter les etats pelliculaires du cuir chevelu
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
DE102012002592A1 (de) * 2012-02-13 2013-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP)
KR102211832B1 (ko) * 2012-06-15 2021-02-02 코나리스 리써치 인스티튜트 아게 니코틴산 및/또는 니코틴아미드 및/또는 트립토판을 포함하는 장내 세균총에 유익한 효능을 가진 조성물
EP3120850B1 (en) * 2012-12-14 2018-11-07 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides

Also Published As

Publication number Publication date
EA201692284A1 (ru) 2017-03-31
JP6446065B2 (ja) 2018-12-26
ZA201607105B (en) 2018-05-30
CN113908074A (zh) 2022-01-11
CN106413680A (zh) 2017-02-15
BR112016024400A2 (pt) 2017-08-15
MX2016014760A (es) 2017-03-06
JP2017515829A (ja) 2017-06-15
EA031758B1 (ru) 2019-02-28
WO2015172801A1 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
PH12016502047A1 (en) Niacinamide for including generation of antimicrobial peptides
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
MX2017016789A (es) Compuestos antibacterianos.
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
EP3310903A4 (en) VASCULARIZED TISSUE, SKIN OR SKIN SKIN EQUIVALENT
EP3685819C0 (en) SOLID ANHYDROUS COSMETIC COMPOSITION, PREPARATION METHOD, COSMETIC TREATMENT PROCESSES AND ASSOCIATED KIT
PH12017500836A1 (en) Transdermal formulations
MX2021010886A (es) Uso de medicamentos para disminuir la evolucion de la enfermedad de parkinson.
MY193650A (en) Extracellular matrix compositions
MX2017011223A (es) Variantes de protoxina ii y metodos de uso.
MX2016009241A (es) Metodos para reducir el mal olor y las bacterias.
IN2014MU00455A (es)
MX2017012654A (es) Variantes de protoxina-ii y metodos de uso.
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
EP3137082A4 (en) Methods to treat, prevent, and improve skin conditions
SG10201900598TA (en) Factor viii formulation
MX368582B (es) Extracto de gardenia para colorear la piel.
HK1246215A1 (zh) 去細胞角膜及其製備方法和用途
MX2016015017A (es) Composiciones dentifricas con estabilidad mejorada del fluoruro.
EP3162358A4 (en) Skin whitening composition containing chemokine
PH12017501979A1 (en) Pharmaceutical compound
NZ783086A (en) Concentrated gibberellin solution formulations
MX2016004961A (es) Procedimientos y composiciones para el tratamiento de infecciones por s. equi.
MX2018008138A (es) Composicion de colorante acuosa y sus usos.